Company Filing History:
5 out of 6 
1 out of 100 
1 out of 2 Years Active: 2020-2023
Title: Geun Eog Ji: Innovator in Sjogren's Syndrome Research
Introduction
Geun Eog Ji is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the area of Sjogren's syndrome. With a total of 5 patents, his work focuses on innovative solutions for health-related issues.
Latest Patents
Geun Eog Ji's latest patents include food and pharmaceutical compositions aimed at inhibiting Sjogren's syndrome. These compositions contain specific strains, C-RAPO (KCTC13986BP) and ATT (KCTC13474BP), which have been disclosed for their effectiveness in inhibiting sialoadenitis, a symptom of Sjogren's syndrome. Additionally, these strains help prevent a reduction in saliva flow rate. The potential applications of these strains extend to the development of food, health food, and pharmaceuticals for the prevention or treatment of Sjogren's syndrome.
Career Highlights
Throughout his career, Geun Eog Ji has worked with notable organizations, including Bifido Co., Ltd. and the Catholic University of Korea Industry-Academic Cooperation Foundation. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in health sciences.
Collaborations
Geun Eog Ji has collaborated with esteemed colleagues such as Myeong Soo Park and Bin Kwon. These partnerships have further enriched his research endeavors and have led to impactful advancements in the field.
Conclusion
Geun Eog Ji's innovative work in the realm of Sjogren's syndrome showcases his dedication to improving health outcomes through research and development. His contributions are paving the way for new treatments and solutions in the medical field.